Sequana Medical announces FDA approval of alfapump

Sequana Medical NV, has announced that it has received Premarket Approval (PMA) from the US Food and Drug Administration (FDA) to market alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis in the United States.